V
Viglacera Tien Son JSC
VN:VIT
Viglacera Tien Son JSC
VN:VIT
Price:
20 000
VND
2.56%
Market Closed
Market Cap:
1T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
VIT Alert
Viglacera Tien Son JSC
20000
+500 (+2.56%)
| 52 Week Range |
14 200
21 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Viglacera Tien Son JSC
Balance Sheet
Balance Sheet Decomposition
Viglacera Tien Son JSC
Viglacera Tien Son JSC
| Current Assets | 989.4B |
| Cash & Short-Term Investments | 24.7B |
| Receivables | 172.7B |
| Other Current Assets | 792B |
| Non-Current Assets | 1.2T |
| Long-Term Investments | 12B |
| PP&E | 1.1T |
| Intangibles | 10.2B |
| Other Non-Current Assets | 38.9B |
| Current Liabilities | 1T |
| Accounts Payable | 255.2B |
| Accrued Liabilities | 49.1B |
| Other Current Liabilities | 730.7B |
| Non-Current Liabilities | 527.6B |
| Long-Term Debt | 526.8B |
| Other Non-Current Liabilities | 863.5m |
Balance Sheet
Viglacera Tien Son JSC
Viglacera Tien Son JSC
Currency: VND
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
20 144
|
5 912
|
117 504
|
9 524
|
40 481
|
67 840
|
108 272
|
65 101
|
45 283
|
23 246
|
|
| Cash |
19 094
|
5 912
|
112 067
|
7 721
|
38 512
|
65 271
|
105 703
|
31 186
|
45 283
|
23 246
|
|
| Cash Equivalents |
1 050
|
0
|
5 437
|
1 803
|
1 969
|
2 569
|
2 569
|
33 914
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
57 095
|
47 966
|
38 121
|
103 559
|
45 537
|
52 158
|
59 729
|
120 538
|
156 841
|
173 453
|
|
| Accounts Receivables |
40 023
|
28 355
|
27 078
|
76 004
|
34 376
|
43 327
|
54 557
|
46 318
|
35 524
|
38 826
|
|
| Other Receivables |
17 072
|
19 612
|
11 044
|
27 555
|
11 161
|
8 831
|
5 172
|
74 219
|
121 317
|
134 627
|
|
| Inventory |
110 563
|
142 298
|
158 936
|
338 699
|
352 397
|
320 377
|
309 215
|
375 719
|
559 269
|
748 185
|
|
| Other Current Assets |
4 821
|
9 607
|
4 212
|
10 616
|
4 191
|
6 307
|
9 327
|
52 578
|
14 182
|
6 569
|
|
| Total Current Assets |
192 624
|
205 784
|
318 773
|
462 397
|
442 606
|
446 681
|
486 542
|
613 935
|
775 575
|
951 454
|
|
| PP&E Net |
291 703
|
432 055
|
407 576
|
602 066
|
543 960
|
515 013
|
446 137
|
1 021 668
|
1 334 086
|
1 234 721
|
|
| PP&E Gross |
291 703
|
432 055
|
407 576
|
602 066
|
543 960
|
515 013
|
446 137
|
1 021 668
|
1 334 086
|
1 234 721
|
|
| Accumulated Depreciation |
242 665
|
280 902
|
334 508
|
393 577
|
464 729
|
519 643
|
571 136
|
644 880
|
734 920
|
724 607
|
|
| Intangible Assets |
16 156
|
13 935
|
13 443
|
12 975
|
13 203
|
12 630
|
12 065
|
11 501
|
10 936
|
10 490
|
|
| Note Receivable |
0
|
278
|
278
|
1 864
|
1 867
|
2 599
|
2 722
|
1 217
|
2 291
|
4 599
|
|
| Long-Term Investments |
13 300
|
13 300
|
13 300
|
13 300
|
13 300
|
13 300
|
13 300
|
12 367
|
12 235
|
12 240
|
|
| Other Long-Term Assets |
33
|
15 738
|
17 250
|
5 277
|
2 511
|
763
|
157
|
1 185
|
71 995
|
46 013
|
|
| Total Assets |
513 815
N/A
|
681 089
+33%
|
770 619
+13%
|
1 097 880
+42%
|
1 017 447
-7%
|
990 987
-3%
|
960 923
-3%
|
1 661 873
+73%
|
2 207 119
+33%
|
2 259 516
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
48 959
|
78 642
|
77 328
|
129 706
|
127 915
|
147 341
|
105 168
|
178 786
|
290 759
|
195 408
|
|
| Accrued Liabilities |
7 146
|
6 525
|
17 474
|
23 131
|
22 476
|
27 246
|
31 354
|
34 427
|
36 832
|
25 821
|
|
| Short-Term Debt |
0
|
0
|
0
|
371 922
|
351 211
|
217 762
|
286 080
|
239 070
|
475 736
|
645 319
|
|
| Current Portion of Long-Term Debt |
195 126
|
225 317
|
273 093
|
78 856
|
80 966
|
88 829
|
90 107
|
175 166
|
106 268
|
181 067
|
|
| Other Current Liabilities |
31 675
|
9 030
|
15 078
|
9 954
|
14 827
|
21 837
|
14 918
|
15 650
|
81 287
|
16 623
|
|
| Total Current Liabilities |
282 906
|
319 513
|
382 972
|
613 568
|
597 395
|
503 014
|
527 627
|
643 098
|
990 882
|
1 064 238
|
|
| Long-Term Debt |
78 014
|
166 703
|
160 704
|
238 309
|
163 478
|
191 182
|
121 928
|
401 782
|
592 100
|
615 294
|
|
| Other Liabilities |
236
|
1 075
|
1 075
|
1 120
|
1 120
|
1 120
|
2 801
|
2 072
|
1 758
|
1 856
|
|
| Total Liabilities |
361 156
N/A
|
487 292
+35%
|
544 752
+12%
|
852 998
+57%
|
761 993
-11%
|
695 317
-9%
|
652 356
-6%
|
1 046 952
+60%
|
1 584 740
+51%
|
1 681 389
+6%
|
|
| Equity | |||||||||||
| Common Stock |
99 000
|
150 000
|
150 000
|
195 000
|
195 000
|
195 000
|
195 000
|
500 000
|
500 000
|
500 000
|
|
| Retained Earnings |
30 992
|
37 304
|
69 375
|
37 708
|
41 139
|
68 165
|
59 414
|
46 167
|
50 912
|
85
|
|
| Additional Paid In Capital |
16 171
|
0
|
0
|
138
|
138
|
138
|
138
|
3 362
|
3 362
|
3 362
|
|
| Treasury Stock |
0
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Equity |
6 496
|
6 496
|
6 496
|
12 316
|
19 456
|
32 647
|
54 295
|
72 120
|
74 832
|
81 407
|
|
| Total Equity |
152 659
N/A
|
193 797
+27%
|
225 868
+17%
|
244 882
+8%
|
255 454
+4%
|
295 670
+16%
|
308 568
+4%
|
614 921
+99%
|
622 379
+1%
|
578 127
-7%
|
|
| Total Liabilities & Equity |
513 815
N/A
|
681 089
+33%
|
770 619
+13%
|
1 097 880
+42%
|
1 017 447
-7%
|
990 987
-3%
|
960 923
-3%
|
1 661 873
+73%
|
2 207 119
+33%
|
2 259 516
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
17
|
18
|
26
|
28
|
28
|
28
|
28
|
50
|
50
|
50
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
